| pubmed-article:12973930 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12973930 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:12973930 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:12973930 | lifeskim:mentions | umls-concept:C1326205 | lld:lifeskim |
| pubmed-article:12973930 | lifeskim:mentions | umls-concept:C1335238 | lld:lifeskim |
| pubmed-article:12973930 | lifeskim:mentions | umls-concept:C1516170 | lld:lifeskim |
| pubmed-article:12973930 | lifeskim:mentions | umls-concept:C0023688 | lld:lifeskim |
| pubmed-article:12973930 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
| pubmed-article:12973930 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:12973930 | pubmed:dateCreated | 2003-9-16 | lld:pubmed |
| pubmed-article:12973930 | pubmed:abstractText | To study the expression of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) in lung cancer cells, and to testify if the PPAR-gamma agonists can inhibit human lung cancer cell growth through induction of apoptosis, PPAR-gamma was detected in two lung cancer cell lines by RT-PCR and immunohistochemistry, the inhibition of human lung cancer cell growth was investigated by MTT and cell counts, and the apoptosis was assessed by TUNEL. The results showed that: (1) PPAR-gamma expressed on two lung cancer cell lines; (2) PPAR-gamma activated by ligands could inhibit human lung cancer cell growth remarkably; (3) PPAR-gamma agonists could induce apoptosis to inhibit lung cancer cell growth. It was concluded that PPAR-gamma expressed in lung cancer cell can be activated by ligands and can inhibit lung cancer cell growth through induction of apoptosis. | lld:pubmed |
| pubmed-article:12973930 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12973930 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12973930 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12973930 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12973930 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12973930 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12973930 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12973930 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12973930 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12973930 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12973930 | pubmed:issn | 1672-0733 | lld:pubmed |
| pubmed-article:12973930 | pubmed:author | pubmed-author:MeraH PHP | lld:pubmed |
| pubmed-article:12973930 | pubmed:author | pubmed-author:ZhangMinM | lld:pubmed |
| pubmed-article:12973930 | pubmed:author | pubmed-author:JinYangY | lld:pubmed |
| pubmed-article:12973930 | pubmed:author | pubmed-author:ZouPingP | lld:pubmed |
| pubmed-article:12973930 | pubmed:author | pubmed-author:TaoXiaonanX | lld:pubmed |
| pubmed-article:12973930 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12973930 | pubmed:volume | 23 | lld:pubmed |
| pubmed-article:12973930 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12973930 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12973930 | pubmed:pagination | 138-40 | lld:pubmed |
| pubmed-article:12973930 | pubmed:dateRevised | 2006-12-14 | lld:pubmed |
| pubmed-article:12973930 | pubmed:meshHeading | pubmed-meshheading:12973930... | lld:pubmed |
| pubmed-article:12973930 | pubmed:meshHeading | pubmed-meshheading:12973930... | lld:pubmed |
| pubmed-article:12973930 | pubmed:meshHeading | pubmed-meshheading:12973930... | lld:pubmed |
| pubmed-article:12973930 | pubmed:meshHeading | pubmed-meshheading:12973930... | lld:pubmed |
| pubmed-article:12973930 | pubmed:meshHeading | pubmed-meshheading:12973930... | lld:pubmed |
| pubmed-article:12973930 | pubmed:meshHeading | pubmed-meshheading:12973930... | lld:pubmed |
| pubmed-article:12973930 | pubmed:meshHeading | pubmed-meshheading:12973930... | lld:pubmed |
| pubmed-article:12973930 | pubmed:meshHeading | pubmed-meshheading:12973930... | lld:pubmed |
| pubmed-article:12973930 | pubmed:meshHeading | pubmed-meshheading:12973930... | lld:pubmed |
| pubmed-article:12973930 | pubmed:meshHeading | pubmed-meshheading:12973930... | lld:pubmed |
| pubmed-article:12973930 | pubmed:meshHeading | pubmed-meshheading:12973930... | lld:pubmed |
| pubmed-article:12973930 | pubmed:meshHeading | pubmed-meshheading:12973930... | lld:pubmed |
| pubmed-article:12973930 | pubmed:meshHeading | pubmed-meshheading:12973930... | lld:pubmed |
| pubmed-article:12973930 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12973930 | pubmed:articleTitle | Peroxisome proliferator-activated receptor-gamma activated by ligands can inhibit human lung cancer cell growth through induction of apoptosis. | lld:pubmed |
| pubmed-article:12973930 | pubmed:affiliation | Institute of Hematology, Xiehe Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022. | lld:pubmed |
| pubmed-article:12973930 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12973930 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12973930 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12973930 | lld:pubmed |
